Skip to main content
. 2015 Aug 5;128(15):2019–2025. doi: 10.4103/0366-6999.161351

Figure 1.

Figure 1

ID4 genes CpG sites methylation frequencies between patients with aplastic anemia and those with myelodysplastic syndrome. ●: One positive CpG site (CG); ○: One negative CpG site (TG). TSS: Transcriptional start site; NBM: Normal bone marrow. The ID4 gene methylation positivity site frequency in patients with myelodysplastic syndrome (29.38% [141/480]) was significantly higher than that of the patients with AA (8.125% [39/480]) (P = 0.000).